Karnataka Health and Family Welfare Minister U.T. Khader on Monday announced that the state government is pursuing a two-pronged strategy to tighten inspections and enforcement across the food and pharmaceutical sectors, responding to a surge in complaints about expired medicines, mislabelling, and inflated drug prices. The announcement came days after Food and Drug Administration (FDA) officials raided warehouses linked to a major e-commerce company in Bengaluru, seizing medicines worth approximately ₹4.2 lakh from two unlicensed storage facilities.

Key Developments

Speaking to reporters in Bengaluru, Minister Khader confirmed that he has convened a meeting with Drugs Control Department officials for Tuesday to deliberate on why pharmaceutical outlets are resorting to malpractices and how such conduct can be curbed. The meeting will also examine the possibility of introducing dedicated guidelines governing the online sale and storage of medicines — an area the government says has grown increasingly difficult to regulate.

'I have called a meeting with officials on Tuesday to discuss why medicinal centres dealing with drugs are resorting to such practices and how they can be controlled,' Khader said.

FDA Raids and Seizures

The urgency of Tuesday's meeting is underscored by raids conducted on Sunday at warehouses associated with a major e-commerce company. FDA officials seized medicines worth ₹2.45 lakh from a premises at Tattanahalli in Anekal taluk, and medicines worth ₹1.57 lakh from a facility in the Devanahalli Aerospace area. Khader confirmed that both locations were operating without the necessary storage licences. The combined seizure of ₹4.2 lakh worth of medicines signals the scale of unlicensed pharmaceutical storage now linked to e-commerce supply chains.

Pricing Disparities and Consumer Impact

Beyond storage violations, Khader drew attention to a widening gap in medicine prices between hospitals and retail pharmacies. He noted that in some instances, hospitals were charging significantly more for the same drugs available at medical shops at nearly half the price, and that mandatory Maximum Retail Price (MRP) labels were not always prominently displayed.

'You go to a hospital, and they charge one rate, while medical shops may provide the same medicine at almost half the price. There is confusion among people in this regard, and we need to address it,' he said.

The minister warned that unchecked pricing practices were pushing economically vulnerable patients deeper into financial distress. 'Many people who are in the Above Poverty Line (APL) category are being pushed into the Below Poverty Line (BPL) category after spending heavily on hospital treatment. They do not know what the margin is — whether it is 50 per cent or 500 per cent,' Khader said.

Centre's Role and State's Limitations

Khader acknowledged that price control of medicines falls primarily under the jurisdiction of the Union government, and called for a more proactive stance from the Centre. He indicated that while Karnataka can strengthen local inspections and enforcement, systemic price regulation requires federal action. The state government has, however, introduced barcodes to streamline the filing and tracking of complaints related to medicines — a step aimed at improving accountability at the ground level.

What Happens Next

Tuesday's meeting is expected to produce a framework covering stronger inspection protocols, regulation of online medicine sales, licensing compliance for storage facilities, and greater transparency in drug pricing and distribution. Khader stressed that while action has been taken against those caught violating norms, many establishments continue to operate undetected. The outcome of the meeting is likely to shape Karnataka's regulatory posture on pharmaceutical e-commerce — a domain that has outpaced existing oversight structures across India.